Media Coverage

Media Coverage

Read how VistaGen’s intention to revolutionize mental health medicine is causing a buzz in the media.

BioSpace Logo
Combatting the Mental Health Crisis with an Acute Treatment Nasal Spray
Read
image thumbnail
UPDATE: VistaGen says regulators couldn’t sniff out abuse potential of its nasal spray for social anxiety
Read
Forbes logo
Diversity Drives Better Outcomes
Read
Psychiatric Times
New Social Anxiety Disorder Drug Differentiates Mechanism of Action
Read
Pharmacy Times
Expert: There is a Dire Need to Improve, More Effectively Treat Mental Health Disorders for Returning Veterans
Read
Nasdaq
This Drug Has the Potential to Become the First FDA-Approved on-Demand Treatment for Social Anxiety
Read
Business Insider logo image
Psychiatric drugs were once a $30 billion business. Analysts say these 9 companies could revive it.
Read
image thumbnail (1)
Karyopharm taps long­time Pfiz­er, Am­gen vet to steer the ship; With Mer­ck in the rearview mir­ror, Roger Perl­mut­ter stakes his claim to a CEO job — and it's a sur­pris­ing choice
Read
image thumbnail
BioSpace Movers & Shakers, May 7
Read